Sketches of Otohistory Part 11: Ototoxicity: Drug-Induced Hearing Loss

  title={Sketches of Otohistory Part 11: Ototoxicity: Drug-Induced Hearing Loss},
  author={Jochen Schacht and Joseph E. Hawkins},
  journal={Audiology and Neurotology},
  pages={1 - 6}
trolled, any untoward action of the drug simply was accepted as inevitable consequence. Secondly, we must consider the status of deafness itself in historic times. Concern for the handicapped was not part of the social fabric of early societies, with the Spartans probably being the most notorious example; in Spartan culture, children born with or suspected of birth defects were tossed off the cliffs. In ancient Israel, those born deaf could not own property or conduct business transactions… 

Figures and Tables from this paper

Auditory Pathology: When Hearing is Out of Balance
The global burden of hearing loss is reflected in the fact that deafness ranks third in the world in “years lived with a disability,” and an even greater number of people may suffer from other disorders of hearing or balance such as tinnitus or Meniere's disease.
Prevalence of ototoxicity in University of Benin Teaching Hospital, Benin city: a 5-year review.
Intravenous quinine was the commonest implicated drug, followed by oral chloroquine, and antihypertensive drugs (nifedipine, moduretics, artenolol), native herbal medicine, and unidentifiable drugs accounted for 53.2%.
Drug-induced hearing loss.
Various factors increase the risk of drug-related hearing loss, including age, dehydration, reduced drug elimination (especially due to renal failure), and co-administration of other ototoxic drugs.
1 Pathology: When Hearing Is Out of Balance
The global burden of hearing loss is reflected in the fact that deafness ranks third in the world in “years lived with a disability” and an even greater number of people may suffer from other disorders of hearing or balance such as tinnitus or Meniere’s disease.
Hearing Impairment Associated with Oral Terbinafine Use
Hearing impairment is described as a possible ADR of oral terbinafine, based on six case reports and statistical support from Vigibase™ and the Lareb database.
Examining the Early Period Effect of Nilotinib on Hearing: An Experimental Study.
Further studies are needed that involve different drug doses, prolonged administration of drugs, as well as distortion otoacoustic emission test for the evaluation of cochlear activation and ABR to prove that nilotinib has definitively no ototoxic effect.
Mechanisms Involved in Ototoxicity.
  • P. Steyger
  • Medicine, Biology
    Seminars in hearing
  • 2011
increased knowledge of the mechanisms by which systemic ototoxins are trafficked across the blood-labyrinth barrier into the inner ear is critical to developing new pharmacotherapeutic agents that target theBlood-Labyrinth barrier to prevent trafficking of ototoxic drugs and their cytotoxic sequelae.
Investigational Medicinal Products for the Inner Ear: Review of Clinical Trial Characteristics in
  • C. L. Le Prell
  • Medicine
    Journal of the American Academy of Audiology
  • 2021
This review provides a comprehensive summary of the state of the science with respect to investigational medicinal products for the inner ear evaluated in human clinical trials, and the current challenges for the field.
Cochleo-vestibular clinical findings among drug resistant Tuberculosis Patients on therapy-a pilot study
A multi-disciplinary close surveillance of MDR and XDR TB patients on therapy is imperative and researches into therapeutic trials on antidotes and potent safer substitutes for aminoglycosides in the management are recommended.
Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk
Evidence from a first-to-human phase 1 clinical trial mirrors animal studies to a large extent, indicating rapid onset and involvement of OHCs and the mechanism(s) of ototoxicity are unknown.


Salicylate attenuates gentamicin-induced ototoxicity.
  • S. Sha, J. Schacht
  • Biology, Medicine
    Laboratory investigation; a journal of technical methods and pathology
  • 1999
It is demonstrated that 2-hydroxybenzoate (salicylate), which can act as an iron chelator and antioxidant, effectively protects against gentamicin-induced hearing loss in guinea pigs and holds promise for clinical application.
Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig.
The discovery of aspirin: a reappraisal
  • W. Sneader
  • Chemistry
    BMJ : British Medical Journal
  • 2000
Analysis of relevant archival and published material now supports Eichengrun's claim that the work had been done under his direction and throws doubt on the reliability of the source crediting Hoffmann.
Some historical aspects of ototoxicity.
The present brief account traces some early reports of ototoxicity from the time of Richard Morton (1692) onwards.
Preliminary clinical experience with cis‐diamminedichloroplatinum (II) (NSC 119875, CACP)
Toxicity to the initial course of CACP, up to 90 mg/m2 BSA, was minimal and transient in most patients, but at higher dosage levels or following repeat courses, the drug‐related toxicity was more severe.
Ototoxicity: bioprotective mechanisms
  • L. Rybak, T. Kelly
  • Biology, Medicine
    Current opinion in otolaryngology & head and neck surgery
  • 2003
This review discusses current research dealing with novel approaches to the prevention of ototoxicity caused by cisplatin and aminoglycoside antibiotics, and provides the potential for exciting clinical trials to determine whether the animal experiments can be translated into rational therapeutic approaches.
On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ
It is suggested that it may be an efficient antiseptic for application to, or injection into, areas infected with penicillin-sensitive microbes, and its value as an aid to the isolation of B. influenzae has been demonstrated.
Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia.
The ototoxic effects of aminoglycosides such as streptomycin, kanamycin and neomycin are well established and since renal failure increases the hazard of ototoxicity from these drugs, it can be expect that these drugs will cause renal failure.
Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. 1944.
The figure captions accompanying this article are incorrect and the two men were co-discoverers of streptomycin.
Streptomycin, a Substance Exhibiting Antibiotic Activity Against Gram-Positive and Gram-Negative Bacteria.∗†
Summary A new antibacterial substance, designated as streptomycin, was isolated from two strains of an actinomyces related to an organism described as Actinomyces griseus. This substance resembles